Vitality Watch

Dossier pubmed review 28-sep-2026
Narrative review or expert overview without new data

Sensory nutrition of sweet taste. Physiological, pathophysiological and pharmacological implications of T1R2/T1R3 signalling pathways on energy (glucose) and body weight homeostasis.

Key claim: T1R2/T1R3 sweet-taste receptors, including extra-oral expression in metabolic tissues, help regulate glucose and body-weight homeostasis and show altered thresholds in aging, obesity, and diabetes, positioning them as potential therapeutic targets.

Abstract

Taste perception plays a key role in food chose. Both taste receptors type 1 member 2 (T1R2) and member 3 (T1R3) are responsible for detecting mono- and disaccharides, and sweet taste perception is dependent of the recognition threshold (RT) of these molecules. Differences in sweet RT are mainly attributed to polymorphisms of T1R2 and T1R3 as well as their expression in taste buds, which are regulated by several hormones including glucagon, ghrelins, glucagon-like peptide, leptins and endocannabinoids. Interestingly, aging, diabetes and obesity are characterized by significant changes in sweet taste threshold, which can influence food intake and consequently contribute to the development of these pathologies. Furthermore, anti-obesity interventions such as caloric restriction, bariatric surgery and pharmacological treatments are also associated with changes in sweet taste perception. These findings suggest a relationship between the components involved in the sweet taste signalling pathways and the mechanisms underlying in the development of these pathologies. The extra-oral expression of T1Rs have been identified in different metabolically active tissues, and its involvement in glycaemic control and body weight control have been demonstrated. These findings may help to explain the afore-mentioned events. This review analyses the physiological and pathophysiological role of T1Rs in the control of energy homeostasis and body weight and the possibility of using them in the prevention of the above-mentioned high prevalence diseases, and as new therapeutic targets.

Why this matters

T1R2/T1R3 sweet-taste receptors, including extra-oral expression in metabolic tissues, help regulate glucose and body-weight homeostasis and show altered thresholds in aging, obesity, and diabetes, positioning them as potential therapeutic targets.

Source

Link

Briefing card

Sensory nutrition of sweet taste. Physiological, pathophysiological and pharmacological implications of T1R2/T1R3 signalling pathways on energy (glucose) and body weight homeostasis.
Stage: review · pubmed · 28-sep-2026

T1R2/T1R3 sweet-taste receptors, including extra-oral expression in metabolic tissues, help regulate glucose and body-weight homeostasis and show altered thresholds in aging, obesity, and diabetes, positioning them as potential therapeutic targets.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.bcp.2026.118510

build build 880 · 2bcef25 · 2026-11-18